Randomized Phase II Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer Patients.
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 22 Jun 2011 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Apr 2010 Planned initiation date changed from 1 Mar 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 14 Apr 2010 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.